Antihistamines like cetirizine hydrochloride are used to treat allergy-related symptoms such hay fever, hives, and allergic conjunctivitis. It functions by inhibiting the effects of histamine, a naturally occurring chemical that the body releases in response to an allergen.
There are several over-the-counter dosage forms of cetirizine hydrochloride, including tablets, capsules, and liquid. It is usually used orally once a day, and it’s crucial to adhere to the dosage recommendations made by your doctor or listed on the medication’s label.
Drowsiness, dry mouth, headaches, and stomach trouble are typical adverse effects of cetirizine hydrochloride. There is a small chance that it will result in more severe side effects like breathing problems or an erratic pulse. It’s crucial to call your doctor or get immediate medical help if you encounter any unexpected symptoms while taking cetirizine hydrochloride.
Global cetirizine hydrochloride market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
The COVID-19 pandemic has had an impact on the size of the global cetirizine hydrochloride market, which is expected to be worth million after being readjusted and growing at a CAGR of 1.7%.
The study also offers insights into the market’s competitive landscape, introducing participants according to their market shares, levels of concentration, etc., and providing a detailed description of the major firms.
Aside from dosage type (solution, pill, and syrup), age group (pediatric and adult), application (eczema, allergic rhinitis, and allergic conjunctivitis), and distribution channel (retail pharmacies, hospital pharmacies, and retail pharmacies), the market is also divided into subgroups.
The research provides information on the top leading market status of the cetirizine hydrochloride industry segmented as , including a geographical study of the key regions The study’s time frame includes several market projections, such as the size and proportion of anticipated obstacles in the future.
The rising frequency of allergic diseases including allergic rhinitis, often known as hay fever, is anticipated to fuel the expansion of the cetirizine hydrochloride market. Around 10% to 30% of people have allergic rhinitis, according to the American Academy of Allergy Asthma & Immunology.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.